Morepen Laboratories Ltd.

View in App
36.54 -0.17 ▼-0.5%

21 September 2023, 04:01:00 PM
Volume: 361,590

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.morepen.com
Market Cap 1,867.81 Cr.
Enterprise Value(EV) 1,836.67 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 0.93 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 39.18 Trailing Twelve Months Ending 2023-06
Industry PE 37.95 Trailing Twelve Months Ending 2023-06
Book Value / Share 15.02 Trailing Twelve Months Ending 2023-06
Price to Book Value 2.43 Calculated using Price: 36.54
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 51.12 Cr. 511,168,708 Shares
FaceValue 2
About Morepen Laboratories Ltd.
Established in the year 1984, Morepen Laboratories is a fast growing Pharmaceutical company listed in all major stock exchanges in India including Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) since 1993 with an investors base of 62,400 shareholders.

Morepen Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Morepen Laboratories Ltd. Performance

View details >>
1 Day
-0.46%
1 Week
-2.43%
1 Month
-1.38%
3 Month
+17.00%
6 Month
+46.16%
1 Year
+15.45%
2 Year
-37.65%
5 Year
+41.63%
10 Year
+1209.68%

Morepen Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.24 7.35 12.54 14.10 12.04 12.50 29.20 21.79 5.93
Return on Capital Employed (%) 2.90 6.29 10.18 14.05 10.01 12.05 27.13 24.86 8.40
Return on Assets (%) 0.44 2.53 4.45 5.30 4.80 5.25 12.76 10.55 3.55

Morepen Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 297 287 300 196 226 253 284 425 579 753
Non Curr. Liab. 85 74 57 18 20 23 28 30 36 37
Curr. Liab. 108 128 167 325 340 339 351 404 456 321
Minority Int. 0 0 -1 -1 0 0 0 0 0 0
Equity & Liab. 490 489 524 538 586 615 663 858 1,070 1,111
Non Curr. Assets 393 374 367 346 342 316 291 331 336 354
Curr. Assets 96 115 157 192 243 299 372 527 734 756
Misc. Exp. not W/O
Total Assets 490 489 524 538 586 615 663 858 1,070 1,111

Morepen Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 401 485 595 607 769 853 1,188 1,547 1,418 1,516
Other Income 1 1 4 4 4 9 12 20 6 8
Total Income 402 486 599 610 772 863 1,200 1,567 1,424 1,524
Total Expenditure -352 -424 -534 -542 -701 -785 -1,070 -1,410 -1,338 -1,425
PBIDT 50 63 65 68 71 78 131 157 86 99
Interest -9 -11 -8 -4 -2 -2 -2 -2 -2 -2
Depreciation -39 -35 -34 -34 -40 -37 -30 -28 -28 -29
Taxation 0 0 0 -6 -1 -25 -17 -20
Exceptional Items -4
PAT 2 13 24 30 29 34 97 102 39 48
Minority Interest 0 0
Share Associate
Other Related Items
Consolidated Net Profit 2 13 24 30 29 34 97 102 39 48
Adjusted EPS 0 0 1 1 1 1 2 2 1 1

Morepen Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 34 51 50 41 63 17 11 51 -60 -91
Cash Fr. Inv. -1 -32 -27 -14 -27 -13 -12 -70 -32 -47
Cash Fr. Finan. -29 -19 -27 -24 -38 0 5 47 66 144
Net Change 4 0 -4 3 -1 4 4 28 -26 6
Cash & Cash Eqvt 9 9 4 7 6 10 14 41 16 22

Morepen Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 34.54 34.54 34.54 38.38 36.74 38.22 38.22 38.22 38.22
Public 65.46 65.46 65.46 61.62 63.26 61.78 61.78 61.78 61.78
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Morepen Laboratories Ltd. Announcements

View details >>
Thu, 21 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached details of loss of share certificates.
Wed, 20 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached issue of letter of confirmation w.r.t. issue of duplicate shares.
Tue, 19 Sep 2023
Announcement under Regulation 30 (LODR)-Change in Management
Mr. Varun Suri Senior Management Personnel of the company has taken over the responsibilities of Morepen Rx Limited Wholly Owned Subsidiary of the company and ceases to be on the payrolls of the Morepen Laboratories Limited.

Morepen Laboratories Ltd. Technical Scans

View details >>
Thu, 21 Sep 2023
Making Lower Lows for 3 days Making Lower Lows for 3 days
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
CCI Oversold Zone CCI Oversold Zone

Morepen Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 274,963.79 1,148.50 -0.4%
Divi's Laboratories Ltd. 99,404.71 3,741.45 -1.0%
Cipla Ltd. 97,455.33 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. 94,594.48 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. 72,171.99 5,023.50 +0.4%
Mankind Pharma Ltd. 69,708.40 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. 63,451.75 1,874.80 -0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.67 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.23 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 31.32 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 20.07 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 108.04 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 54.38 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.36 1,874.80 -0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.75 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.57 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-06 4.00 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.86 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.52 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.69 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.65 1,874.80 -0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 0.02 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 12.85 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,874.80 -0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,874.80 -0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,148.50 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,741.45 -1.0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,207.15 -2.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,685.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,023.50 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,740.15 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,874.80 -0.5%

Morepen Laboratories Ltd. FAQ's

What is Morepen Laboratories share price?
Can I buy Morepen Laboratories shares now?
What is the Market Cap of Morepen Laboratories?
What are the key metrics to analyse Morepen Laboratories?
What is the 52 Week High and Low of Morepen Laboratories?
What is the trend of Morepen Laboratories share price?